Clinical trial
AVIDA The Vidaza® (Azacitidine) Patient Registry
NCT00481273 · Celgene, Industry · Completed
Key facts
| NCT number | NCT00481273 |
|---|---|
| Title | AVIDA The Vidaza® (Azacitidine) Patient Registry |
| Official title | AVIDA The Vidaza® (Azacitidine) Patient Registry |
| Acronym | AVIDA |
| Lead sponsor | Celgene, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Azacitidine |
| Enrollment | 479 |
| Start date | Oct 31, 2006 |
| Primary completion | Aug 31, 2010 |
| Completion | Aug 31, 2010 |
| First posted | Jun 1, 2007 |
| Last update posted | May 3, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: